GD2 expression in breast cancer

Breast cancer (BC) is a heterogeneous disease, including different subtypes having diverse incidence, drug-sensitivity and survival rates. In particular, claudin-low and basal-like BC have mesenchymal features with a dismal prognosis. Disialoganglioside GD2 is a typical neuroectodermal antigen expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Orsi, Giulia, Barbolini, Monica, Ficarra, Guido, Tazzioli, Giovanni, Manni, Paola, Petrachi, Tiziana, Mastrolia, Ilenia, Orvieto, Enrico, Spano, Carlotta, Prapa, Malvina, Kaleci, Shaniko, D’Amico, Roberto, Guarneri, Valentina, Dieci, Maria Vittoria, Cascinu, Stefano, Conte, Pierfranco, Piacentini, Federico, Dominici, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458232/
https://www.ncbi.nlm.nih.gov/pubmed/28415563
http://dx.doi.org/10.18632/oncotarget.16363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458232/
https://www.ncbi.nlm.nih.gov/pubmed/28415563
http://dx.doi.org/10.18632/oncotarget.16363

Ejemplares similares